Welcome to APR Applied Pharma Research s.a.
We are a wholly owned subsidiary of the publicly traded company Relief Therapeutics Holding AG (SIX: RLF.SW, OTCQB: RLFTF, OTCQB: RLFTY as US ADR)

We identify, develop and commercialize best-in-class, patent-protected products in selected rare and ultra-rare disease areas on a global basis

OUR PURPOSE

We help patients and care givers dealing with rare and ultra-rare diseases to live their best possible life and exploit their full potential

Get the
clinical pipeline

PKU GOLIKE KRUNCH: the NEW protein substitute to chew.

PKU GOLIKE, a real change in the dietary management of PKU.

PKU GOLIKE in the world.

We use patented drug delivery systems and platform to identify, develop and commercialize science driven products improving patients' quality of life in niche and rare therapeutic areas.

Get

We leverage our advanced patented technologies and world-class pharma development expertise to deliver to patients and caregivers innovative products with meaningful benefits.

Get

We market our products directly through our own sale and marketing teams in selected countries of Europe.

Get

We count on an extensive network of partnerships with pharmaceutical companies internationally sized in over 70 countries.

Get

As a vertically integrated contract development company, we provide added-value R&D services under contract and fee-paying basis.

Get

APR - Applied Pharma Research

Your Swiss Pharma Company

APR Applied Pharma Research s.a. (APR) is a Swiss, private Pharma company, located in Balerna (Ticino area), the science valley in the southern part of Switzerland.

The company is focused on development and commercialization of innovative, science-driven products designed to address unmet needs in niche or rare therapeutic areas on a global basis.

APR combines drug development expertise with proprietary drug delivery technologies to deliver to patients suffering from rare diseases with solutions meaningfully improving their life and empowering caregivers with better ways to manage such rare diseases.

APR Portfolio

APR has a balanced portfolio of revenue-generating branded products marketed in all major markets, combined with a compelling pipeline of innovative products at different stages of development, specifically in the treatment of rare recessive metabolic disorders, rare dermatological and ocular diseases.

Our main marketed products are:

PKU GOLIKE®, an innovative food for special medical purposes (FSMP) consisting of a Phe-free amino acid mixture, powered by the patented Physiomimic™ Technology, for Phenylketonuria (PKU) dietary management
Nexodyn® AcidOxidizing Solution (AOS), the advanced wound cleanser for acute and chronic wound management, powered by the patented Tehclo™ Technology Platform
An immediate release formulation of Diclofenac K for the treatment of migraine and acute pain powered by the patented Dynamic Buffering Technology;
Setofilm®, an oral film formulation of Ondansetron indicated for cancer supportive care (in the treatment of CINV, RINV and PONV), powered by the patented Oral Dispersible Film (ODF) technology;

Using various delivery technologies, APR has also developed some Category OTC Healthcare Brands such as Halykoo® and SwitzAGE™.

HalyKoo® consists of a complete range of high-quality health care solutions specifically tailored to baby needs, while SwitzAGE™ is an innovative range of nutraceuticals, 100% Swiss made, specifically created to meet adults' wellbeing needs.

Services

APR provides a wide range of services for the pharmaceutical industry on a contract basis and on a fee for service basis: research and development services with complete supervision, management and execution of the entire project, development of oral and topical formulations and customized drug delivery technologies.

Some of APR's products are commercialized directly through its own sale and marketing teams in selected countries of Europe (Italy, Germany, Switzerland and Austria) as well as through a solid global network of commercial partners in all other countries worldwide.

Discover more about us.

back

APR
Applied Pharma Research s.a.
Via Corti 5, CH - 6828 Balerna,
Switzerland
Phone: +41 91 6957020